YAVNE, Israel, Oct. 11, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today ...
(RTTNews) - Biopharmaceutical company MediWound Ltd. (MDWD) Wednesday announced its partnership with 3M Health Care for the Phase 3 study of MediWound's lead drug candidate EscharEx to treat patients ...
MediWound to join forces with 3M Health Care, world’s largest wound care company in pivotal study for patients with venous leg ulcers YAVNE, Israel, Oct. 11, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback